Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) EBT: 2009-2024

Historic EBT for ProPhase Labs (PRPH) over the last 16 years, with Dec 2024 value amounting to -$42.3 million.

  • ProPhase Labs' EBT rose 6.38% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.4 million, marking a year-over-year increase of 0.56%. This contributed to the annual value of -$42.3 million for FY2024, which is 88.99% down from last year.
  • Latest data reveals that ProPhase Labs reported EBT of -$42.3 million as of FY2024, which was down 88.99% from -$22.4 million recorded in FY2023.
  • In the past 5 years, ProPhase Labs' EBT ranged from a high of $22.9 million in FY2022 and a low of -$42.3 million during FY2024.
  • For the 3-year period, ProPhase Labs' EBT averaged around -$13.9 million, with its median value being -$22.4 million (2023).
  • Per our database at Business Quant, ProPhase Labs' EBT soared by 331.82% in 2022 and then tumbled by 197.77% in 2023.
  • ProPhase Labs' EBT (Yearly) stood at -$2.3 million in 2020, then surged by 329.26% to $5.3 million in 2021, then soared by 331.82% to $22.9 million in 2022, then tumbled by 197.77% to -$22.4 million in 2023, then crashed by 88.99% to -$42.3 million in 2024.